- Home
- IT vs ILMN Comparison
IT vs ILMN Comparison
Compare IT & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IT
- ILMN
- Stock Information
- Founded
- IT 1979
- ILMN 1998
- Country
- IT United States
- ILMN United States
- Employees
- IT N/A
- ILMN N/A
- Industry
- IT Other Consumer Services
- ILMN Medical Specialities
- Sector
- IT Consumer Discretionary
- ILMN Health Care
- Exchange
- IT Nasdaq
- ILMN Nasdaq
- Market Cap
- IT 17.9B
- ILMN 15.3B
- IPO Year
- IT 1993
- ILMN 2000
- Fundamental
- Price
- IT $230.57
- ILMN N/A
- Analyst Decision
- IT Hold
- ILMN
- Analyst Count
- IT 10
- ILMN
- Target Price
- IT $313.33
- ILMN N/A
- AVG Volume (30 Days)
- IT 1.0M
- ILMN N/A
- Earning Date
- IT 11-04-2025
- ILMN 11-10-2025
- Dividend Yield
- IT N/A
- ILMN N/A
- EPS Growth
- IT N/A
- ILMN N/A
- EPS
- IT 11.49
- ILMN N/A
- Revenue
- IT $6,459,775,000.00
- ILMN N/A
- Revenue This Year
- IT $6.61
- ILMN N/A
- Revenue Next Year
- IT $4.16
- ILMN N/A
- P/E Ratio
- IT $20.06
- ILMN N/A
- Revenue Growth
- IT 5.24
- ILMN N/A
- 52 Week Low
- IT $222.54
- ILMN N/A
- 52 Week High
- IT $584.01
- ILMN N/A
- Technical
- Relative Strength Index (RSI)
- IT 39.37
- ILMN 66.82
- Support Level
- IT $222.54
- ILMN $118.50
- Resistance Level
- IT $238.73
- ILMN $126.00
- Average True Range (ATR)
- IT 9.80
- ILMN 5.02
- MACD
- IT -2.01
- ILMN 2.48
- Stochastic Oscillator
- IT 18.80
- ILMN 84.61
About IT Gartner Inc.
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.